Biotechnology Industry

sector

Last mentioned: Feb 23, 2026

Timeline

  1. Quicker Path Formalized

    Official rollout of the streamlined regulatory framework for gene therapy approvals.

  2. CBER Staffing Surge

    FDA completes hiring of 100+ new reviewers dedicated to biologics and gene therapy.

  3. START Pilot Program

    FDA launches the Support for clinical Trials Advancing Rare disease Therapeutics pilot.

  4. First Gene Therapy Approved

    FDA approves Luxturna for a rare form of inherited vision loss.

Stories mentioning Biotechnology Industry 1

regulation Bullish

FDA Accelerates Gene Therapy Approvals with New Regulatory Framework

The FDA has launched a streamlined regulatory pathway designed to expedite the development and review of gene therapies, particularly for rare diseases. This initiative marks a significant shift toward using surrogate endpoints and flexible trial designs to bring life-saving treatments to market faster.

8 sources